ESSA Pharma Inc.
Androgen receptor modulators and methods for their use
Last updated:
Abstract:
The present invention relates to compounds of formula (I)-(VI) and/or (A)-(H-I), or any subgenera thereof, or a pharmaceutically acceptable salt, tautomer or stereoisomer. The compounds of the present disclosure are useful in modulating androgen receptor activity and for treating cancer including prostate cancer.
Status:
Grant
Type:
Utility
Filling date:
20 Apr 2020
Issue date:
13 Jul 2021